What's new? Log in Free sign up

NeuBase Therapeutics (NBSE) News and press releases

Company Profile

News

From Benzinga Pro

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

NeuBase Therapeutics Reports Business Update And Financial Results For Q1 Of FY23; As Of December 31, 2022, The Company Had Cash And Cash Equivalents Of ~$17.4M

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision

NeuBase Therapeutics Q1 EPS $(0.13) Beats $(0.20) Estimate

NeuBase Therapeutics (NASDAQ:NBSE) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.20) by 35 percent. This is a 45.83 percent increase over losses of $(0.24) per share from

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a leading transportation and industrial equipment provider.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Press releases

From Benzinga Pro

NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023

Earnings, Press Releases

PITTSBURGH, Feb. 14, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.